Fig. 2
From: Macular structural integrity estimates are associated with Parkinson’s disease genetic risk
(A) Polygenic risk scoring analysis in the Raine Study (Gen2), which included two time point measurements (20 and 28 years of age) and longitudinal changes of three OCT outcome variables: GCIPL, pRNFL, and overall macular thickness. (B) Study design to evaluate the genetic overlap between ganglion-cell structural estimates (i.e., macula RNFL and GCIPL) and Parkinson’s disease